This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Colon Carcinoma or Rectum Carcinoma
and you are
between 18 and 120
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Comparative evaluation of recurrence-free survival (RFS) time and 3 year overall survival (OS) time between the treatment groups (L-BLP25 plus cyclophosphamide versus placebo and saline infusion).

Provided treatments

  • Biological: L-BLP25
  • Biological: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01462513. The sponsor of the trial is Prof. Dr. Carl Schimanski and it is looking for 122 volunteers for the current phase.
Official trial title:
LICC: L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases - a Randomized, Placebo-controlled, Multicenter, Multinational, Double Blinded Phase II Trial